Sonoma Pharmaceuticals, Inc.
SNOA
$5.09
$0.030.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.57% | 27.27% | -7.16% | 58.89% | 19.39% |
| Total Depreciation and Amortization | -7.69% | -24.39% | -26.67% | -22.22% | -13.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -204.93% | 1,458.62% | -106.82% | -76.19% | -17.92% |
| Change in Net Operating Assets | -456.52% | -82.77% | 495.15% | 777.67% | -111.33% |
| Cash from Operations | -120.94% | -162.50% | 151.18% | 128.76% | -324.19% |
| Capital Expenditure | -2,020.00% | -361.11% | -100.00% | -1,200.00% | 70.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,020.00% | -361.11% | -100.00% | -1,200.00% | 70.59% |
| Total Debt Issued | -- | -26.54% | -- | -- | -- |
| Total Debt Repaid | 31.93% | 13.83% | 35.94% | 5.43% | 8.46% |
| Issuance of Common Stock | -96.95% | -85.71% | -45.18% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.12% | -61.09% | -46.28% | 1,219.38% | 571.11% |
| Foreign Exchange rate Adjustments | 258.91% | 154.29% | -301.79% | -528.89% | -383.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.20% | -80.89% | 330.48% | 205.83% | -95.29% |